[Exogenous mineralocorticoid hypertension: pathogenetic and clinical considerations].
Armanini
D
D
D000818:Animals; D002229:Carbenoxolone / Q000009:adverse effects; D003937:Diagnosis, Differential; D005477:Fluprednisolone / Q000009:adverse effects / Q000031:analogs & derivatives; D006035:Glycyrrhiza; D006801:Humans; D006929:Hyperaldosteronism / Q000175:diagnosis; D006973:Hypertension / Q000139:chemically induced* / Q000175:diagnosis; D008901:Mineralocorticoids / Q000009:adverse effects*; D010946:Plants, Medicinal; D051381:Rats
D008901:Mineralocorticoids; C010958:9-fluoroprednisolone; D005477:Fluprednisolone; D002229:Carbenoxolone
Ipertensione da mineralcorticoidi esogeni. Considerazioni patogenetiche e cliniche.